Healionics, Inc.
Seattle, US · Delaware corporation · 4 known investors
Healionics develops STARgraft, a synthetic vascular graft built on its STAR biomaterial scaffold that resists occlusion and infection to create a reliable bloodstream access site for kidney dialysis patients. The device has received FDA Breakthrough Device designation and targets the treatment of kidney failure through dialysis.
Founders & leadership
MC
Mike ConnollyExecutive Officer, Director
AM
Andrew MarshallDirector
RT
Ryan TakeuchiDirector
BR
Buddy RatnerDirector
AC
Arthur CouryDirector
MM
Max MaginnessExecutive Officer
Investors · 4
Reported raises · per SEC filings
Form D private placements▶$2MraisedDec 2025 · 30 investors · OtherRule 506(b)
▶$2MraisedDec 2025 · 30 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Mike ConnollyExecutive Officer, Director
- Andrew MarshallDirector
- Ryan TakeuchiDirector
- Buddy RatnerDirector
- Arthur CouryDirector
- Offering amount
- $20M
- Amount sold
- $2M
- First sale
- Dec 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.5MraisedFeb 2024 · 70 investors · OtherRule 506(b)
▶$5.5MraisedFeb 2024 · 70 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Buddy RatnerDirector
- Arthur CouryDirector
- Mike ConnollyExecutive Officer, Director
- Ryan TakeuchiDirector
- Andrew MarshallDirector
- Offering amount
- $5.6M
- Amount sold
- $5.5M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.6MraisedDec 2020 · 86 investors · OtherRule 506(b)
▶$6.6MraisedDec 2020 · 86 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Andrew MarshallDirector
- Arthur CouryDirector
- Mike ConnollyExecutive Officer, Director
- Buddy RatnerDirector
- Ryan TakeuchiDirector
- Offering amount
- $10.2M
- Amount sold
- $6.6M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.2MraisedJul 2019 · 72 investors · OtherRule 506(b)
▶$4.2MraisedJul 2019 · 72 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Buddy RatnerDirector
- Mike ConnollyExecutive Officer, Director
- Arthur CouryDirector
- Andrew MarshallDirector
- Max MaginnessExecutive Officer
- Ryan TakeuchiDirector
- Offering amount
- $5M
- Amount sold
- $4.2M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.